newsfilter
← Latest News
Business Wire·

Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma

Eganelisib Remains Primary Value Driver for Infinity Infinity to Explore Strategic Alternatives to Maximize Value for Stockholders Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) ("Infinity"), a clinical-stage